Cargando…

Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study

BACKGROUND: There is a class I recommendation for implantable cardioverter-defibrillator deactivation discussions to occur between physicians and heart failure patients. Few studies have reported the patient’s perspective on the timing of implantable cardioverter-defibrillator deactivation discussio...

Descripción completa

Detalles Bibliográficos
Autores principales: MacIver, Jane, Tibbles, Alana, Billia, Filio, Ross, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830094/
https://www.ncbi.nlm.nih.gov/pubmed/27110361
http://dx.doi.org/10.1177/2050312116642693
_version_ 1782426856304148480
author MacIver, Jane
Tibbles, Alana
Billia, Filio
Ross, Heather
author_facet MacIver, Jane
Tibbles, Alana
Billia, Filio
Ross, Heather
author_sort MacIver, Jane
collection PubMed
description BACKGROUND: There is a class I recommendation for implantable cardioverter-defibrillator deactivation discussions to occur between physicians and heart failure patients. Few studies have reported the patient’s perspective on the timing of implantable cardioverter-defibrillator deactivation discussions. AIM: To determine patient awareness, preferences and timing of implantable cardioverter-defibrillator deactivation discussions. DESIGN: Grounded theory was used to collect and analyze interview data from 25 heart failure patients with an implantable cardioverter-defibrillator. SETTING AND PARTICIPANTS: Patients with an implantable cardioverter-defibrillator, from the Heart Function Clinic at University Health Network (Toronto, Canada). RESULTS: The sample (n = 25) was predominately male (76%) with an average age of 62 years. Patients identified three stages where they felt implantable cardioverter-defibrillator deactivation should be discussed: (1) prior to implantation, (2) with any significant deterioration but while they were of sound mind to engage in and communicate their preferences and (3) at end of life, where patients wished further review of their previously established preferences and decisions about implantable cardioverter-defibrillator deactivation. Most patients (n = 17, 68%) said they would consider deactivation, six (24%) were undecided and two (8%) were adamant they would never turn it off. CONCLUSION: The patient preferences identified in this study support the need to include information on implantable cardioverter-defibrillator deactivation at implant, with change in clinical status and within broader discussions about end-of-life treatment preferences. Using this process to help patients determine and communicate their implantable cardioverter-defibrillator deactivation preferences may reduce the number of patients experiencing distressing implantable cardioverter-defibrillator shocks at end of life.
format Online
Article
Text
id pubmed-4830094
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-48300942016-04-22 Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study MacIver, Jane Tibbles, Alana Billia, Filio Ross, Heather SAGE Open Med Original Article BACKGROUND: There is a class I recommendation for implantable cardioverter-defibrillator deactivation discussions to occur between physicians and heart failure patients. Few studies have reported the patient’s perspective on the timing of implantable cardioverter-defibrillator deactivation discussions. AIM: To determine patient awareness, preferences and timing of implantable cardioverter-defibrillator deactivation discussions. DESIGN: Grounded theory was used to collect and analyze interview data from 25 heart failure patients with an implantable cardioverter-defibrillator. SETTING AND PARTICIPANTS: Patients with an implantable cardioverter-defibrillator, from the Heart Function Clinic at University Health Network (Toronto, Canada). RESULTS: The sample (n = 25) was predominately male (76%) with an average age of 62 years. Patients identified three stages where they felt implantable cardioverter-defibrillator deactivation should be discussed: (1) prior to implantation, (2) with any significant deterioration but while they were of sound mind to engage in and communicate their preferences and (3) at end of life, where patients wished further review of their previously established preferences and decisions about implantable cardioverter-defibrillator deactivation. Most patients (n = 17, 68%) said they would consider deactivation, six (24%) were undecided and two (8%) were adamant they would never turn it off. CONCLUSION: The patient preferences identified in this study support the need to include information on implantable cardioverter-defibrillator deactivation at implant, with change in clinical status and within broader discussions about end-of-life treatment preferences. Using this process to help patients determine and communicate their implantable cardioverter-defibrillator deactivation preferences may reduce the number of patients experiencing distressing implantable cardioverter-defibrillator shocks at end of life. SAGE Publications 2016-04-07 /pmc/articles/PMC4830094/ /pubmed/27110361 http://dx.doi.org/10.1177/2050312116642693 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
MacIver, Jane
Tibbles, Alana
Billia, Filio
Ross, Heather
Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study
title Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study
title_full Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study
title_fullStr Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study
title_full_unstemmed Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study
title_short Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study
title_sort patient perceptions of implantable cardioverter-defibrillator deactivation discussions: a qualitative study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830094/
https://www.ncbi.nlm.nih.gov/pubmed/27110361
http://dx.doi.org/10.1177/2050312116642693
work_keys_str_mv AT maciverjane patientperceptionsofimplantablecardioverterdefibrillatordeactivationdiscussionsaqualitativestudy
AT tibblesalana patientperceptionsofimplantablecardioverterdefibrillatordeactivationdiscussionsaqualitativestudy
AT billiafilio patientperceptionsofimplantablecardioverterdefibrillatordeactivationdiscussionsaqualitativestudy
AT rossheather patientperceptionsofimplantablecardioverterdefibrillatordeactivationdiscussionsaqualitativestudy